Canadian drug makers hit with $1.1B suit for pushing opioids despite risks

TORONTO — Canadian drug makers are facing a $1.1-billion lawsuit for their role in the opioid crisis. A proposed class action filed today accuses almost two dozen companies of enriching themselves at the expense of vulnerable patients. The unproven suit alleges the companies illegally and deceptively promoted highly addictive opioids despite knowing the dangers The […]